Results 211 to 220 of about 2,637,082 (312)
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
Diabetes-Technology and Waste: The Future is Now. [PDF]
Heinemann L, Seid DA, Klonoff DC.
europepmc +1 more source
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette +13 more
wiley +1 more source
Awareness of Vital Complications and Associated Factors Among Type 2 Diabetic Patients in Al-Hudaydah, Yemen: A Cross-Sectional Study. [PDF]
Alselwy K, Saeed M.
europepmc +1 more source
Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery [PDF]
Taylor R. Lansberry, Cherie L. Stabler
openalex +1 more source
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source
New methods of glucose self-control
Editorial team Diabetes Mellitus
doaj +1 more source
Salivary Metal Ions as Potential Biomarkers for Diabetes: An Observational Study. [PDF]
Ding Z +8 more
europepmc +1 more source
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren's disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source
Editorial: New trends in type 2 diabetes diagnosis and management in primary care, volume II. [PDF]
Klisic A, Tzeng IS, Mercantepe F.
europepmc +1 more source

